883554-46-9

Upstream product

• 883554-45-8 4,4'-methylenebis[(1R,1'S,2S,2'R,6R,6'S)-6-acetoxy-2-chlorocyclohept-3-en-1-yl]bis(4-methoxybenzoate) 

Downstream Products

• 883554-51-6 (1S,6R)-6-hydroxy-4-{[(4R,6S)-6-{(2R)-2-(4-methoxybenzoyl)oxy}-4-{[tert-butyldimethylsilyloxy]butyl}-2,2-dimethyl-1,3-dioxan-4-yl]methyl}cyclohept-3-en-1-yl 4-methoxybenzoate 
• 883554-50-5 (1S,6R)-6-hydroxy-4-{(2R,4S,6R)-2,4,8-trihydroxy-6-[(4-methoxybenzoyl)oxy]octyl}cyclohept-3-en-1-yl 4-methoxybenzoate 
• 883554-49-2 (1S,6R)-6-hydroxy-4-[{(1R,2S,4S,6R)-1,2,6-trihydroxy-4-[(4-methoxybenzoyl)oxy]cyclohept-1-yl}methyl]cyclohept-3-en-1-yl 4-methoxybenzoate 
• 883554-47-0 (1S,6R)-6-acetoxy-4-[{(1'R,2'S,4'R,6'S)-6-acetoxy-1,2-dihydroxy-4-[(4-methoxybenzoyl)oxy]cyclohept-1-yl}methyl]cyclohept-3-en-1-yl 4-methoxybenzoate 

Relevant academic research and scientific papers

Asymmetric synthesis of the polyol subunit of the polyene macrolide antibiotic RK-397

A total asymmetric synthesis of the polyol subunit of the polyene macrolide antibiotic RK-397 has been developed by the stereoselective functionalization of (1R,1′S,6S,6′R)-3,3′-methylenebis(cyclohept-3-ene-1,6-diol) . The pathway generates a large variet